| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/24/2007 | EP1744757A1 Improved nsaid composition |
| 01/24/2007 | EP1744750A2 Pharmaceutical composition comprising hydrophobic drug having improved solubility |
| 01/24/2007 | EP1744737A2 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 01/24/2007 | EP1744731A1 Oral formulation for delivery of poorly absorbed drugs |
| 01/24/2007 | EP1744729A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/24/2007 | EP1744683A2 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 01/24/2007 | EP1503714A4 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/24/2007 | EP1487497B1 Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment |
| 01/24/2007 | EP1450785B1 Method of treating dermatoses using avermectin compound |
| 01/24/2007 | EP1448236B1 Inclusion complex of taxol with 2-hxdroxypropyl-beta-cyclodextrin |
| 01/24/2007 | EP1423100B1 Plaster comprising sertaconazole for the treatment of dysfunctions and disorders of nails |
| 01/24/2007 | EP1418894B1 Transdermal therapeutic system with fentanyl |
| 01/24/2007 | EP1345594B1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 01/24/2007 | EP1339386B1 Reversible gelling system for ocular drug delivery |
| 01/24/2007 | EP1280531B1 Formulation consisting of phentolamine mesylate and the use thereof |
| 01/24/2007 | EP1257285B1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/24/2007 | EP1181363B1 Recombinant human mannan-binding lectin |
| 01/24/2007 | EP1067908B9 Taxane microemulsions |
| 01/24/2007 | EP1049712B1 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/24/2007 | EP1024812B1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
| 01/24/2007 | EP0961783B1 Polysaccharide conjugates of biomolecules |
| 01/24/2007 | CN1902352A Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 01/24/2007 | CN1902254A Medicinal compositions and method for the preparation thereof |
| 01/24/2007 | CN1902232A Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use |
| 01/24/2007 | CN1902160A Non-symmetrical gelling agent |
| 01/24/2007 | CN1901943A Methods of inhibiting the adherence of lenses to their packaging materials |
| 01/24/2007 | CN1901936A Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 01/24/2007 | CN1901935A Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
| 01/24/2007 | CN1901923A Disinfecting composition and methods of making and using same |
| 01/24/2007 | CN1901922A Compositions and uses thereof |
| 01/24/2007 | CN1901905A Intranasal compositions |
| 01/24/2007 | CN1901894A Inhibitor imaging agents |
| 01/24/2007 | CN1901885A Melt blend dispersions comprising a low water solubility drug and an ethylene oxide-propylene oxide block copolymer |
| 01/24/2007 | CN1901839A Soluble TCR molecules and methods of use |
| 01/24/2007 | CN1900144A Poly propenoic acid/polypeptide grafted copolymer and its preparing method and use |
| 01/24/2007 | CN1899644A Methods and apparatus for improved administration of pharmaceutically active compounds |
| 01/24/2007 | CN1899621A Nano emulsus micro emulsion composition and method for producing its products |
| 01/24/2007 | CN1899620A Micro emulsion substance for cosmetics and medicine and its preparing method |
| 01/24/2007 | CN1899619A Process for preparing water soluble cyclodextrin-C60 super molecule inclusion compound |
| 01/24/2007 | CN1899618A Process for preparing micro crystal cellulose milk sugar |
| 01/24/2007 | CN1899617A Compound econazole nitrate film forming gel composition and its use |
| 01/24/2007 | CN1899553A Paste for treating dental hyperesthesia and its preparing method |
| 01/24/2007 | CN1899446A Wolfberry fruit tablet health product and its preparing method |
| 01/24/2007 | CN1899441A Chinese medicine paste for burn and its preparing method |
| 01/24/2007 | CN1899413A Loquat leaf total triterpenic acid Chinese medicine preparation for treating chronic bronchitis |
| 01/24/2007 | CN1899388A Shuangdan soft capsule and its preparing method |
| 01/24/2007 | CN1899339A Medicinal composition for treating acute and chronic conjunctivitis for eye and its preparing method |
| 01/24/2007 | CN1899296A Breviscapine B injection preparation and its preparing method |
| 01/24/2007 | CN1899292A Triamcinolone benetonide local film forming gel composition |
| 01/24/2007 | CN1899290A Epristeride slow release preparation |
| 01/24/2007 | CN1899288A Quetiapine granules |
| 01/24/2007 | CN1899287A Slow release medicinal composition for treating anxiety and its preparing method |
| 01/24/2007 | CN1899272A Stabilized compositions of aqueous reduced coenzyme q solution |
| 01/24/2007 | CN1899271A Sevoflurane storage method and methods for inhibiting their degradation in the presence of a lewis acid |
| 01/24/2007 | CN1899270A Medical super fire micro capsule capsaicine and its preparing method |
| 01/24/2007 | CN1899269A Hollow quick soluble film capsule |
| 01/24/2007 | CN1899267A Valsartan dripping pill and its preparing method |
| 01/24/2007 | CN1899266A Medicinal micro pill core and its preparing method |
| 01/24/2007 | CN1899265A Medical dust cloud agent or granular agent and its use |
| 01/24/2007 | CN1899264A Temperature sensitive type water gel medicine release system and its preparing method |
| 01/24/2007 | CN1296477C Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 01/24/2007 | CN1296391C Compound of fluorinated carboxy alkyl cyclic starch gun ester kind and preparation process and application thereof |
| 01/24/2007 | CN1296387C Cellulose powder |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/24/2007 | CN1296337C Alkoxylates exhibiting low residual alcohol content |
| 01/24/2007 | CN1296098C Oral insulin protecting agent |
| 01/24/2007 | CN1296097C Polymer micelle medicine-carrying system |
| 01/24/2007 | CN1296096C Poxvirus-containing formulations and process for preparing stable, poxvirus containing compositions |
| 01/24/2007 | CN1296095C Improved mycoplasma hyopneumoniae bacterin vaccine |
| 01/24/2007 | CN1296089C Zedoary injection preparation and its preparing method |
| 01/24/2007 | CN1296040C Medicinal composition |
| 01/23/2007 | US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/23/2007 | US7166733 Antitumor agents |
| 01/23/2007 | US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 01/23/2007 | US7166702 Used to treat inflammatory responses associated with activation, proliferation and migration of immune effector cells, including leukocyte cell types, neutrophils, macrophages, and eosinophils |
| 01/23/2007 | US7166695 Affinity markers for human serum albumin |
| 01/23/2007 | US7166692 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 01/23/2007 | US7166571 Immobilization; antidiabetic agents |
| 01/23/2007 | US7166305 granules of starch which have been expanded or preswelled and crosslinked, followed by reaction with a polyvalent Ca, Mg, Zn Cu, or Al metal salt; |
| 01/23/2007 | US7166304 Degradable heterobifunctional poly(ethylene glycol) acrylates |
| 01/23/2007 | US7166303 An aqueous solution comprising of propofol, poloxamers; noncontamination, stability |
| 01/23/2007 | US7166302 Complexing agents for compositions containing inclusion complexes |
| 01/23/2007 | US7166299 Comprises ursodeoxycholic acid for treating gastritis and peptic ulcer disease |
| 01/23/2007 | US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
| 01/23/2007 | US7166296 Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1 |
| 01/23/2007 | US7166295 Methods of treatment and diagnostic visualization, particularly in cancer |
| 01/23/2007 | US7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers |
| 01/23/2007 | CA2456970C Drug formulations for parenteral use |
| 01/23/2007 | CA2407325C Low ionic strength ophthalmic compositions |
| 01/23/2007 | CA2348086C Controlled-release pharmaceutical formulations |
| 01/23/2007 | CA2345466C Sustained release, and comfortable ophthalmic composition and method for ocular therapy |
| 01/23/2007 | CA2277956C Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
| 01/23/2007 | CA2245804C Recombinant ribonuclease proteins |
| 01/23/2007 | CA2216169C Use of compositions comprising stabilized biologically effective compounds |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/18/2007 | WO2007008778A2 Formulations for enhanced mucosal delivery of pyy |
| 01/18/2007 | WO2007008769A2 Use of pseudan and pseudan inclusion bodies |
| 01/18/2007 | WO2007008563A2 Preparation of pegylated conjugates of vla-4 antagonists via a mitsunobu' s reaction |
| 01/18/2007 | WO2007008350A1 Pharmaceutical formulations of endo-n-(9- methyl-9-azabicyclo[3 .3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride |
| 01/18/2007 | WO2007008206A1 Dilution resistant viscoelastic compositions |